Attached files

file filename
EX-1 - EXHIBIT 1.1 - M.D.C. HOLDINGS, INC.ex1-1.htm
EX-99 - EXHIBIT 99.1 - M.D.C. HOLDINGS, INC.ex99-1.htm

 



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report: January 7, 2014

 

 

M.D.C. Holdings, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

(State or Other Jurisdiction

of Incorporation)

1-8951

(Commission

File Number)

84-0622967

(IRS Employer

Identification #)

 

4350 South Monaco Street, Suite 500
Denver, Colorado 80237

(Address of Principal Executive Offices)

 

(303) 773-1100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 210.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

 
 

 

 

ITEM 1.01.

ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

 

On January 7, 2014, M.D.C. Holdings, Inc. (the “Company”) and certain of its subsidiaries entered into an Underwriting Agreement with Citigroup Global Markets Inc. (the “Representative”), as representative of the several underwriters named in Schedule II thereto (the “Underwriters”), in connection with the offering and sale of an aggregate principal amount of $250 million of 5.500% Senior Notes due 2024 (the “Notes”). The offering is being made pursuant to the Company’s registration statement on Form S-3ASR (Registration No. 333-190359), as supplemented by the prospectus supplement dated January 7, 2014.

 

The Underwriting Agreement contains customary representations, warranties and agreements by the Company, and customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is filed as Exhibit 1.1 hereto and incorporated by reference herein.

 

The Company expects to receive net proceeds, after the underwriting discount and estimated offering expenses, of approximately $248.1 million. The offering of the Notes is expected to close on January 15, 2014.

 

ITEM 8.01.

OTHER EVENTS

 

The Company’s press release announcing the transaction is attached as Exhibit 99.1.

 

ITEM 9.01. 

FINANCIAL STATEMENTS AND EXHIBITS

 

 

(d)

Exhibits

 

Exhibit No.

 

Description

     

1.1

 

Underwriting Agreement dated as of January 7, 2014, by and among the Company, certain of its subsidiaries as guarantors, and Citigroup Global Markets Inc., as representative of the several underwriters named in Schedule II thereto.

     

4.1

 

Indenture dated as of December 3, 2002, by and among M.D.C. Holdings, Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.2 of the Company’s Form S-3/A filed on September 1, 2004).

     

99.1

 

Press release dated January 7, 2014.

 

 

 

 
 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

M.D.C. HOLDINGS, INC.

 

 

 

 

 

 

 

 

 

 

 

 Dated: January 8, 2014

 

By: 

/s/ Joseph H. Fretz

 

 

 

 

Joseph H. Fretz

 

 

 

 

Secretary and Corporate Counsel

 

 

 

 
 

 

 

Exhibit Index

 

Exhibit No.

 

Description

     

1.1

 

Underwriting Agreement dated as of January 7, 2014, by and among the Company, certain of its subsidiaries as guarantors, and Citigroup Global Markets Inc., as representative of the several underwriters named in Schedule II thereto.

     

4.1

 

Indenture dated as of December 3, 2002, by and among M.D.C. Holdings, Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.2 of the Company’s Form S-3/A filed on September 1, 2004).

     

99.1

 

Press release dated January 7, 2014.